Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely zinc (as zinc acetate) 50 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Zinc (as zinc acetate) 25 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Erythromycin- and zinc acetate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing zinc acetate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing diphenhydramine and zinc acetate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Diphenhydramine 2%/zinc acetate 0.1% topical cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing zinc acetate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing zinc acetate in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Zinc acetate dihydrate (substance) |
Is a |
False |
Zinc acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely zinc (as zinc acetate) 50 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Zinc (as zinc acetate) 25 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Zinc acetate dihydrate (substance) |
Is modification of (attribute) |
True |
Zinc acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely zinc (as zinc acetate) 50 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Zinc acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Zinc (as zinc acetate) 25 mg oral capsule |
Has precise active ingredient |
True |
Zinc acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution |
Has precise active ingredient |
False |
Zinc acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution |
Has basis of strength substance (attribute) |
False |
Zinc acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Zinc acetate-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only zinc acetate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Erythromycin and zinc acetate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Diphenhydramine and zinc acetate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing erythromycin and zinc acetate in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only zinc acetate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Erythromycin and zinc acetate only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Zinc acetate only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only diphenhydramine and zinc acetate in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Diphenhydramine hydrochloride 20 mg/mL and zinc acetate 1 mg/mL cutaneous cream |
Has precise active ingredient |
True |
Zinc acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Diphenhydramine hydrochloride 20 mg/mL and zinc acetate 1 mg/mL cutaneous cream |
Has basis of strength substance (attribute) |
True |
Zinc acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing diphenhydramine and zinc acetate in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution |
Has basis of strength substance (attribute) |
True |
Zinc acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution |
Has precise active ingredient |
True |
Zinc acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Zinc acetate anhydrous (substance) |
Is modification of (attribute) |
True |
Zinc acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|